ARROWHEAD PHARMACEUTICALS IN's ticker is and the CUSIP is 04280A900. A total of 4 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $881,336 | -19.0% | 32,800 | +7.5% | 0.00% | – |
| Q2 2023 | $1,087,630 | +33.0% | 30,500 | -5.3% | 0.00% | – |
| Q1 2023 | $817,880 | -56.5% | 32,200 | -30.6% | 0.00% | -100.0% |
| Q4 2022 | $1,881,984 | -32.7% | 46,400 | -45.2% | 0.00% | 0.0% |
| Q3 2022 | $2,796,000 | +83.8% | 84,600 | +95.8% | 0.00% | 0.0% |
| Q2 2022 | $1,521,000 | – | 43,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 56,600 | $301,000 | 0.00% |
| Citadel Advisors | 31,300 | $167,000 | 0.00% |
| SIMPLEX TRADING, LLC | 58 | $5,000 | 0.00% |